SOCS3 and metabolic dysfunction-associated steatotic liver disease: Indeed, recent observations suggest that the SOCS3-JAK-STAT3 signaling pathway, activated by cytokines, plays a significant role in MASLD by promoting lipid accumulation and the infiltration of neutrophils and macrophages into the liver, increasing inflammation [34].